BMRA
Biomerica·NASDAQ
--
--(--)
--
--(--)
BMRA fundamentals
Biomerica (BMRA) Revenue Breakdown: Q2 2026 Business & Regional Performance
Biomerica (BMRA) reported total revenue of 1.21M USD in Q2 2026, with its core business segment Clinical Lab contributing 55.87%. Regionally, Asia remained the largest market, accounting for 29.59% of total revenue. Explore Biomerica's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Biomerica (BMRA) reported total revenue of 1.21M USD in Q2 2026, with its core business segment Clinical Lab contributing 55.87%. Regionally, Asia remained the largest market, accounting for 29.59% of total revenue. Explore Biomerica's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Biomerica's earnings call?What guidance did Biomerica's management provide for the next earnings period?What were the key takeaways from Biomerica’s earnings call?What is Biomerica's latest dividend and current dividend yield?What is the market's earnings forecast for Biomerica next quarter?Did Biomerica beat or miss consensus estimates last quarter?What factors drove the changes in Biomerica's revenue and profit?What is the revenue and EPS growth rate for Biomerica year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
